393 results on '"Salles, Jean Pierre"'
Search Results
102. SHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core protein
103. Two novel mutations of the calcium-sensing receptor gene affecting the same amino acid position lead to opposite phenotypes and reveal the importance of p.N802 on receptor activity
104. Bone defects in LPA receptor genetically modified mice
105. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature
106. ChemInform Abstract: New 3′-Azido-3′-deoxythymidin-5′-yl O-(ω-Hydroxyalkyl) Carbonate Prodrugs: Synthesis and Anti-HIV Evaluation.
107. Functional Effects of PTPN11 (SHP2) Mutations Causing LEOPARD Syndrome on Epidermal Growth Factor-Induced Phosphoinositide 3-Kinase/AKT/Glycogen Synthase Kinase 3β Signaling
108. Adsorption and release of BMP‐2 on nanocrystalline apatite‐coated and uncoated hydroxyapatite/β‐tricalcium phosphate porous ceramics
109. Hypophosphatasia may lead to bone fragility: don’t miss it
110. X-linked nephrogenic diabetes insipidus: From the ship hopewell to RFLP studies
111. Detection of the A189G mtDNA heteroplasmic mutation in relation to age in modern and ancient bones
112. Potential role of phospholipase D2 in increasing interleukin-2 production by T-lymphocytes through activation of mitogen-activated protein kinases ERK1/ERK2
113. Genetic and Pharmacological Targeting of Phosphoinositide 3-Kinase-γ Reduces Atherosclerosis and Favors Plaque Stability by Modulating Inflammatory Processes
114. The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway
115. Signal Strength Dictates Phosphoinositide 3-Kinase Contribution to Ras/Extracellular Signal-Regulated Kinase 1 and 2 Activation via Differential Gab1/Shp2 Recruitment: Consequences for Resistance to Epidermal Growth Factor Receptor Inhibition
116. Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi Syndrome.
117. The Adaptor Protein Gab1 Couples the Stimulation of Vascular Endothelial Growth Factor Receptor-2 to the Activation of Phosphoinositide 3-Kinase
118. Selective Activation of Nuclear Phospholipase D-1 by G Protein–Coupled Receptor Agonists in Vascular Smooth Muscle Cells
119. Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine
120. A Novel Role for Gab1 and SHP2 in Epidermal Growth Factor-induced Ras Activation
121. PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes
122. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization
123. Hyperghrelinemia Is a Common Feature of Prader-Willi Syndrome and Pituitary Stalk Interruption: A Pathophysiological Hypothesis
124. SHIP-2 and PTEN Are Expressed and Active in Vascular Smooth Muscle Cell Nuclei, but Only SHIP-2 Is Associated with Nuclear Speckles
125. Synthesis of a New Family of Glycolipidic Nitrones as Potential Antioxidant Drugs for Neurodegenerative Disorders.
126. Modulation of phosphoinositide 3-kinase activation by cholesterol level suggests a novel positive role for lipid rafts in lysophosphatidic acid signalling
127. A lysophosphatidic acid analogue is revealed as a potent inhibitor of phosphatidylcholine synthesis, inducing apoptosis
128. Human epidermis is a novel site of phospholipase B expression
129. Apoptotic Effect of Sphingosine 1-Phosphate and Increased Sphingosine 1-Phosphate Hydrolysis on Mesangial Cells Cultured at Low Cell Density
130. Synthesis of New Covalently Bound κ-Carrageenan−AZT Conjugates with Improved Anti-HIV Activities
131. Identification of a Region Critical for Proteolysis of the Human Growth Hormone Receptor
132. New 3‘-Azido-3‘-deoxythymidin-5‘-yl O-(4-Hydroxyalkyl or -Alkenyl or -Alkylepoxide) Carbonate Prodrugs: Synthesis and Anti-HIV Evaluation
133. New 3‘-Azido-3‘-deoxythymidin-5‘-yl O-(ω-Hydroxyalkyl) Carbonate Prodrugs: Synthesis and Anti-HIV Evaluation
134. Polymorphism of the 5' Untranslated Region of NHE1 Gene Associated with Type-I Diabetes
135. Effect of Sphingosine‐1‐phosphate and Analogues of Lysophosphatidic Acid on Mesangial Cell Proliferation
136. Do calcium-channel blockers and glucocorticoids impair no production in ischaemic heart disease patients?
137. Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis
138. Platelet sodium-proton exchange rates in young adults with a history of childhood hypertension
139. Platelet Na+-H+ exchange in juvenile diabetes mellitus
140. Synthesis of a new family of glycolipidic nitrones as potential antioxidant drugs for neurodegenerative disorders
141. Identification of a Novel Mutation in the Human Growth Hormone Receptor Gene (GHR) in a Patient with Laron Syndrome.
142. Can antidepressants unlock prescription of rimonabant in the fight against COVID-19?
143. From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling.
144. F. Pourpoint et al.: High-resolution solid state NMR experiments for the characterization of calcium phosphate biomaterials and biominerals
145. Cross-sectional Association of 10 Molecular Markers of Bone, Cartilage, and Synovium with Disease Activity and Radiological Joint Damage in Patients with Hip Osteoarthritis: The ECHODIAH Cohort*
146. Lipocortin‐like anti‐phospholipase A2activity of endonexin
147. Lipocortin-like anti-phospholipase A 2activity of endonexin
148. Final heights in 398 patients with X-linked hypophosphatemia (XLH) over the last decades in France, a surrogate marker of improved disease management. Study of a large cohort of XLH patients born between 1950 and 2006
149. Lipocortin‐like anti‐phospholipase A2 activity of endonexin
150. Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.